NYSE:CBInsurance
Chubb VCT Alliance Puts Clinical Trial Risk And Valuation In Focus
Chubb (NYSE:CB) has entered into an alliance with Verified Clinical Trials (VCT) to support clinical trial risk management.
The agreement centers on integrating VCT's subject registry technology into Chubb's offerings for life science and clinical research clients.
The partnership is intended to address operational, financial, regulatory, and liability risks while supporting participant safety and data quality.
For investors watching NYSE:CB, this move sits directly in Chubb's specialty...